Vertex Pharmaceuticals
VRTX
#175
Rank
โ‚ฌ100.30 B
Marketcap
391,21ย โ‚ฌ
Share price
-0.41%
Change (1 day)
-9.96%
Change (1 year)

Vertex Pharmaceuticals (VRTX) - Total debt

Total debt on the balance sheet as of September 2025 : โ‚ฌ1.57 Billion

According to Vertex Pharmaceuticals's latest financial reports the company's total debt is โ‚ฌ1.57 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

Vertex Pharmaceuticals - Total debt on balance sheet (from 1996 to 2025)

Total debt by year

Year Total debt Change
2024-12-31โ‚ฌ1.68 B129.9%
2023-12-31โ‚ฌ0.73 B-12.81%
2022-12-31โ‚ฌ0.83 B-1.81%
2021-12-31โ‚ฌ0.85 B12.75%
2020-12-31โ‚ฌ0.75 B28.27%
2019-12-31โ‚ฌ0.59 B15.15%
2018-12-31โ‚ฌ0.51 B1.49%
2017-12-31โ‚ฌ0.50 B-36.77%
2016-12-31โ‚ฌ0.79 B5.78%
2015-12-31โ‚ฌ0.75 B11.41%
2014-12-31โ‚ฌ0.67 B84.91%
2013-12-31โ‚ฌ0.36 B-30.38%
2012-12-31โ‚ฌ0.52 B50.06%
2011-12-31โ‚ฌ0.35 B-13.03%
2010-12-31โ‚ฌ0.40 B275.99%
2009-12-31โ‚ฌ0.10 B-47.79%
2008-12-31โ‚ฌ0.20 B1401.59%
2007-12-31โ‚ฌ13.69 M-85.4%
2006-12-31โ‚ฌ93.78 M-38.31%
2005-12-31โ‚ฌ0.15 B-38.44%
2004-12-31โ‚ฌ0.24 B-6.76%
2003-12-31โ‚ฌ0.26 B-15.62%
2002-12-31โ‚ฌ0.31 B-15.38%
2001-12-31โ‚ฌ0.37 B-3.56%
2000-12-31โ‚ฌ0.38 B5382.91%
1999-12-31โ‚ฌ7.01 M-15.06%
1998-12-31โ‚ฌ8.25 M16.67%
1997-12-31โ‚ฌ7.07 M-1.18%
1996-12-31โ‚ฌ7.16 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Gilead Sciences
GILD
โ‚ฌ21.42 B 1,259.33%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
โ‚ฌ59.04 B 3,646.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
โ‚ฌ35.53 B 2,154.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚ฌ43.83 B 2,681.83%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
โ‚ฌ39.33 B 2,395.91%๐Ÿ‡บ๐Ÿ‡ธ USA
Enanta Pharmaceuticals
ENTA
โ‚ฌ49.85 M-96.84%๐Ÿ‡บ๐Ÿ‡ธ USA